to baseline assessment of erectile function. These findings suggest that despite the known association between select comorbid conditions, medications, and ED, the presence of these conditions does not result in a more rapid deterioration in erectile function over time compared to cases with no comorbid conditions. This information provides a significant addition to our current understanding of the natural history of ED progression.
INTRODUCTION AND OBJECTIVES: Surgical therapy for benign prostatic hyperplasia (BPH) is amongst the most common urological procedures. While most patients are expected to resume sexual activity postoperatively, data pertaining to the required time of abstinence is lacking.
METHODS: Following IRB approval, we prospectively enrolled sexually active men referred for BPH surgery in a questionnaire-based study. Patients were asked to complete an IPSS, IIEF and the sexual part of the EPIC questionnaires (assessing BPH severity, erectile and sexual function) a month before and after their surgery. Upon discharge, patients were advised to resume sexual activity whenever they desired without indicating a specific period of abstinence. To study urologists' perspectives in this context, we approached board certified urologists, asking them to complete a short questionnaire assessing their current practice and recommendations.
RESULTS: Of the 71 participating patients, roughly half underwent endoscopic surgery (Table 1) . Over 80% of patients were older than 60 and over 90% were married. The postoperative IPSS improved significantly, while no difference was detected in the IIEF and EPIC scores. Almost all patients (94%) patients reported on resuming sexual activity less than a month postoperatively and more than 40% within 2 weeks. Two thirds reported on retrograde ejaculation and 11 % reported on mild bleeding. Although more than 20% experienced some pain during orgasm, only 10% decided to refrain temporarily from further sexual activity. Overall, 70 urologists completed the questionnaire (table 2). More than 94% worked at academic centers, most had more than 10 years experience, and over 50% indicated performing at least 60 surgeries yearly. More than 50% would recommend abstaining from any sexual activity for at least 1 month postoperatively.
CONCLUSIONS: While most urologists recommend refraining from sexual activity for at least one month following BPH surgery, our study suggests that over 94% of patients may resume sexual activity shortly after surgery, expecting minimal adverse side effects. Herein, we introduced tertiary referral hospital experiences of men presenting with painless PCGH and tried to suggest a tentative management algorithm. METHODS: Between 2009 and July 2016, data from 20 first-visit patients with PCGH were reviewed. After checking present illness and past history, further studies were performed by our tentative management algorithm for painless PCGH (Figure 1) . At first, the general work-up for painless gross hematuria including laboratory test, CT, and urethrocystoscopy was performed. If no discernable reason for PCGH was identified, the focused work-up of PCGH for pelvic vasculatures was carried out as follows. Transrectal and penile ultrasonogrphay (USG) with Doppler study were performed for the evaluation of prostate, penis, and their relevant vasculatures. Diagnostic pelvic angiography and subsequent angioembolization were recommended at the physician 0 s discretion.
Source of
RESULTS: The median age was 47 years (31~67). After following of our tentative algorithm, there was no abnormal finding in 9 (45.0%), urological malignancies were found in 2 (10.0%; 1 bladder, 1 kidney). On urethrocystoscopy, urethral mucosal bulging suggestive of hemangioma was found in 3 (15.0%) (Figure 2A ). Doppler USG revealed pelvic varicosities in 3 (15.0%), and pelvic arteriovenous malformation (AVM) in 3 (15.0%) ( Figure 2B, C) . Pelvic angiography was recommended to the latter 3 patients for confirmatory diagnosis. One refused angiography, but the other 2 patients underwent angiography and subsequent angioembolization for AVM ( Figure 2D~F) . CONCLUSIONS: PCGH is a different disease entity from painless GH. The focused work-up for the pelvic vasculatures seems to be mandatory for the evaluation of these patients. The feasibility of our tentative algorithm should be evaluated by well designed clinical studies. METHODS: Patients in Trial NCT02232425 recorded IELT measured by stopwatch and 2 PEP questions (ejaculation control and ejaculation-related distress) using an e-diary daily during 4 weeks prior to treatment and 8 weeks of study drug treatment. Patients also completed all 4 PEP questions every 4 weeks, and the CGIC at end of treatment. PEP questions on control and distress were scored 0 (worst) to 4 (best response). Treatment groups were analyzed together. IELT, CGIC and PEP results were systematically compared. Descriptive statistics, correlation coefficients (Pearson and Spearman) and Bland-Altman plots were produced for each treatment interval. Box and whisker plots were produced by category of improvement in PEP question scales.
Source of Funding: None
RESULTS: Data collected daily via e-Diary and based on 4-week recall showed equivalent results (Figure 1 shows results for distress). Each endpoint was sensitive to treatment-related change, and all measures showed a high degree of concordance with one another. For example, improvements in IELT correlated with improved control and reduction in ejaculation-related distress (Figure 2 ). Men with lifelong PE generally perceived improvement in their condition when their IELT increased by approximately 40 seconds or more, or the fold increase in IELT was 2.5 or greater.
CONCLUSIONS: The results strongly support the use of these efficacy instruments in PE studies. The combination of objective (IELT) and subjective (PEP, CGIC) measures is necessary and appropriate for assessing treatment benefit in men with PE.
